
OrthoSystems Inc (AKA: Advanced Resonance Technologies Inc) Profile last edited on: 6/19/2019
CAGE: 3M6A2
UEI: P6QQJF456L83
Business Identifier: Diagnostic tools for detection of chemical and biological targets Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
Location: Single
Congr. District: 24
County: Onondaga
Congr. District: 24
County: Onondaga
Public Profile
OrthoSystems Inc, formerly known as Advanced Resonance Technologies Inc and spun out of technology developed at Syracuse University, is a biotechnology company developing switch technology capable of a) creating rapid diagnostic tools for detection of chemical and biological targets, and b) leveraging this diagnostic platform for drug discovery applications. OrthoSwitch, OrthoSystems' platform technology, has demonstrated the ability of transducing molecular recognition of biological targets into a real-time (seconds) optical signal for identifying environmental and terrorist released contaminants in liquid systems. OrthoSwitch solutions are built on patent-pending biotechnology based on years of leading-edge biological research and industry partnerships at Syracuse University
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
5-9Revenue Range
.5M-1MVC funded?
NoPublic/Private
Privately HeldStock Info
----IP Holdings
N/AAwards Distribution by Agency
Most Recent SBIR Projects
Year | Phase | Agency | Total Amount | |
---|---|---|---|---|
2011 | 2 | NIH | $1,781,638 | |
Project Title: Simple Dna/Rna Probes For Protein Targets | ||||
2010 | 1 | NIH | $195,561 | |
Project Title: Aptamer Probes For Epigenetic Peptide Targets | ||||
2009 | 2 | NIH | $1,249,198 | |
Project Title: Microarray chips for rapid detection of high affinity nucleic acid sequences | ||||
2006 | 2 | NIH | $853,149 | |
Project Title: Improved NMR Sample Tubes | ||||
2005 | 2 | NIH | $851,587 | |
Project Title: OrthoSwitch Probes for High Throughput Screening |
Key People / Management
Philip N Borer -- President
Company News
Jan
02
2005
|
How CNY can turn college research into jobs |